By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ekos 



Bothell  Washington    U.S.A.
Phone: 425-482-1108 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ekos Initiates A Pivotal New Study In Patients With Chronic Deep Vein Thrombosis And Post-Thrombotic Syndrome 6/11/2014 8:11:10 AM
Ekos' Ekosonic ® Endovascular System Receives FDA Clearance 5/23/2014 6:43:11 AM
Ekos Release: Acute Pulmonary Embolism Trial Confirms Safety And Efficacy Of Ultrasound Accelerated Endovascular Thrombolysis 3/31/2014 8:40:32 AM
Ekos Release: Pulmonary Embolism Trial Comparing Endovascular Ultrasound To Standard Of Care Anticoagulation Published In The American Heart Association’s Journal, Circulation 1/20/2014 10:50:06 AM
BTG plc (BTG.L) Buys Ekos for Up to $420 Mllion 5/23/2013 8:02:27 AM
Ekos Announces U.S. Enrollment Completion of the SEATTLE II Trial that Studies the Safety and Efficacy of Ultrasound Accelerated Thrombolysis for Treatment of Massive and Submassive Pulmonary Embolism 3/20/2013 10:38:08 AM
Ekos Announces Two More Pulmonary Embolism Clinical Studies 5/3/2012 10:28:53 AM
Ekos Wins European Approval for Ultrasound Clot Buster in the Lungs 1/18/2011 7:11:35 AM
Ekos, Swedish Aim to Shake Up Stroke Treatment with Ultrasound Brain Clot Buster 3/5/2010 7:41:48 AM
Ekos Announces a Groundbreaking Study for the Treatment of Intracerebral and Intraventricular Hemorrhage Using Ultrasound Presented at the American Heart AssociationInternational Stroke Conference 2010 2/25/2010 11:08:03 AM
123
//-->